Pancreatic Cancer: Research-driven Clinical Progress Examined at AACR Special Conference
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
Progress Against Cancer
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
As you prepare for trick-or-treating, check out the articles selected by the editors of the 10 AACR journals for...
Neuroblastoma, a rare cancer that occurs primarily in children, is a scientific paradox, said pediatric oncologist John M. Maris,...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
Forum for patient advocates explores how researchers are working to develop cancer treatments in a quicker, more efficient manner.
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...
Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids...
Researchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even...